Sensient Technologies Corporation filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
$SXT
Major Chemicals
Industrials
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
(Date of Report/Date of earliest event reported)
(Exact name of registrant as specified in its charter)
|
|
|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
(Address and zip code of principal executive offices)
(414 ) 271-6755
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
| Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
The Company held its annual meeting of shareholders on April 24, 2025. At that meeting, the Company’s shareholders voted on three matters as follows:
Election of Directors
The following directors were each elected until the next annual meeting of shareholders and until his or her successor is elected and, if necessary, qualified:
|
Nominee
|
Votes
For
|
Votes
Against
|
Abstentions
|
Broker
Non-Votes
|
|
Brett W. Bruggeman
|
37,200,896
|
511,740
|
21,338
|
1,313,437
|
|
Dr. Joseph Carleone
|
37,018,800
|
695,757
|
19,417
|
1,313,437
|
|
Dr. Mario Ferruzzi
|
37,108,352
|
607,282
|
18,340
|
1,313,437
|
|
Carol R. Jackson
|
37,525,379
|
182,570
|
26,026
|
1,313,437
|
|
Sharad P. Jain
|
37,362,662
|
352,199
|
19,114
|
1,313,437
|
|
Dr. Donald W. Landry
|
36,854,181
|
846,654
|
33,140
|
1,313,437
|
|
Paul Manning
|
36,425,714
|
1,255,563
|
52,698
|
1,313,437
|
|
Deborah McKeithan-Gebhardt
|
37,438,134
|
269,762
|
26,078
|
1,313,437
|
|
Scott C. Morrison
|
37,250,133
|
465,182
|
18,660
|
1,313,437
|
|
Essie Whitelaw
|
37,451,455
|
265,428
|
17,091
|
1,313,437
|
Advisory Vote to Approve Named Executive Officer Compensation
The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Company’s 2025
proxy statement, by the following votes:
|
Votes For
|
Votes Against
|
Abstentions
|
Broker Non-Votes
|
|||
|
35,705,764
|
1,914,009
|
114,202
|
1,313,437
|
Ratification of Independent Auditors
The Company’s shareholders ratified the appointment of Ernst & Young LLP as the Company’s independent auditors for the year ending December 31, 2025 by
the following votes:
|
Votes For
|
Votes Against
|
Abstentions
|
||
|
38,634,839
|
373,416
|
39,157
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
authorized.
|
SENSIENT TECHNOLOGIES CORPORATION
|
|||
|
By:
|
/s/ John J. Manning
|
||
|
Name:
|
John J. Manning
|
||
|
Title:
|
Senior Vice President, General Counsel, and Secretary
|
||
|
Date:
|
April 30, 2025
|
||